Note: Not all studies are available based on copyrights of the original documents. Please note the PARI Pharma copyright studies are owned by PARI Pharma. Data may not be referenced in any way including print and electronic formats without the prior written consent of PARI Pharma.

[DDL 12-03 020] J. Jauernig, S. Ohl, M. Luber, M. Keller: Differences in Results Obtained with the Next Generation Impactor (NGI) for Pulmicort® Suspension and According to the CEN Standard EN-13544-1 for a NaF-Solution. Drug Delivery to the Lungs XIV, London, United Kingdom, December 11-12, 2003 (oral presentation). Proceedings pp. 41 – 44 (extended abstract).
[DDL 12-03 019] R. Stangl: Quality Control of Inhalers for Clinical Studies. Drug Delivery to the Lungs XIV, London, United Kingdom, December 11-12, 2003 (poster presentation). Proceedings pp. 168 – 171 (extended abstract).
[DDL 12-03 018] M. Tservistas, A. Balcke, P. Stempfle, K. Reul, M. Keller, M. Knoch: Nebuliser systems and formulation characteristics: Two factors effecting in-vitro inhaler system performance for cystic fibrosis treatment. Drug Delivery to the Lungs XIV, London, United Kingdom, December 11-12, 2003 (poster presentation). Proceedings pp. 176 – 179 (extended abstract).
[AAPS 10-03 017] F.-C. Lintz, S. von Opolski, M. Keller: Nebulization Perspectives Utilizing a Customized Electronic Inhaler (eFlow™) for Pulmonary Administration of Drug Products. AAPS Annual Meeting, Salt Lake City, USA, October 26-30, 2003 (poster).
[AAPS 10-03 016] G. Lang, D. Jahn, A. Bucholski, M. Keller: Assessment of Tobramycin and its impurities by a novel rapid and simple derivatization method. AAPS Annual Meeting, Salt Lake City, USA, October 26-30, 2003 (poster).
[MF 10-03 015] J.-C. Stein: The Design of Droplet Inhalers: What is important and what is not? Aqueous Droplet Inhalers: Conference organised by Management Forum, London, October 20 – 21, 2003 (oral presentation).
[MF 10-03 014] M. Keller: Formulations Options and Challenges for Aqueous Inhalation Drug Products. Aqueous Droplet Inhalers: Conference organised by Management Forum, London, October 20 – 21, 2003 (oral presentation).
[NACF 10-03 013] A. Bucholski, M. Keller, A. Balcke, F.-C.-Lintz, S. Seemann, W. D. Flitter, T. Hofmann, K. W. Stapleton: In-Vitro Performance of eFlow™, an Electronic Inhaler for Administration of a Novel Aztreonam Formulation to CF Patients. 17th Annual North American Cystic Fibrosis Conference, Anaheim, USA, October 16 – 19, 2003 (poster).
[NACF 10-03 012] M. Keller, A. Balcke, M. Tservistas, A Bucholski, P. Stempfle, R. Stangl, M. Knoch: Reduced Treatment Time for Tobramycin Application by Device and Formulation Customization. 17th Annual North American Cystic Fibrosis Conference, Anaheim, USA, October 16 – 19, 2003 (poster).
[ERS 09-03 011] M. Borgschulte, R. Stangl, M. Keller, M. Knoch: Improvement of Pulmonary Drug Delivery by eFlow™, a Novel Electronic Inhaler Making Use of a Vibrating Membrane Principle. European Respiratory Society Annual Congress 2003, Wien, Austria, September 27 – October 1, 2003 (poster).
[ERS 09-03 010] J. Smart, F. Lintz: A preliminary assessment of the stability of 5-CF containing liposomes following aerosolisation with TouchSpray™ Technology and nebulisation with a commercial jet nebuliser. European Respiratory Society Annual Congress 2003, Wien, Austria, September 27 – October 1, 2003 (poster).
[ISAM 06-03 009] M. Tservistas, E. Sommer, M. Knoch, G. Hunziker: Ultrasonic and Perforated-Mesh Nebulizers: Fundamental Differences in Function and Performance. International Society for Aerosols in Medicine (ISAM), 14th International Congress, Baltimore, Maryland, USA, June 14 – 18, 2003 (poster). Journal of Aerosol Medicine, 16, 2, 2003, p. 190 (abstract).
[ISAM 06-03 008] M. Keller, P. Stempfle, K. Reul, R. Waldner, F.-C. Lintz, S. von Opolski, G. Menges, S. Seemann, K. Stapleton: High Efficiency Pulmonary Drug Delivery of a Novel Formulation of Aztreonam by the eFlow™. International Society for Aerosols in Medicine (ISAM), 14th International Congress, Baltimore, Maryland, USA, June 14 – 18, 2003 (poster). Journal of Aerosol Medicine, 16, 2, 2003, p. 194 (abstract).
[ISAM 06-03 007] R. Stangl, R. Waldner, S. Seemann, M. Knoch: In-vitro Characterisation of the eFlow™ Electronic Inhaler. International Society for Aerosols in Medicine (ISAM), 14th International Congress, Baltimore, Maryland, USA, June 14 – 18, 2003 (poster). Journal of Aerosol Medicine, 16, 2, 2003, p. 197 (abstract).
[ECFC 06-03 006] A. Balcke, M. Tservistas, U. Schuschnig, P. Stempfle, K. Reul, M. Knoch, M. Keller: Effect of nebuliser systems on the in-vitro nebulisation efficiency of Tobramycin solutions. 26th European Cystic Fibrosis Conference (ECFC), Belfast, Northern Ireland, June 4 – 7, 2003 (poster).
[ATS 05-03 005] K. G. Schuepp, M. Keller, J. Jauernig, R. Stangl, H. M. Janssens, H. A. W. M. Tiddens, J. H. Wildhaber: Assessment of a Novel Budesonide Solution and Electronic Inhaler (eFlow™) utilizing a Baby Cast Model applying different Breathing Patterns. ATS 99th International Conference, Seattle, USA, May 16-21, 2003 (poster). Am. J. Respir. Crit. Care Med. 167 (2003) No 7, Supplement, p. A507 (abstract)
[ATS 05-03 004] M. Keller, F.-C. Lintz, S. von Opolski, U. Schuschnig, B. Flitter, T. Hofmann: Perspektives in Nebulization of the Monobactam Antibiotic Aztreonam by an Electonic Inhaler (eFlow™). ATS 99th International Conference, Seattle, USA, May 16-21, 2003 (poster). Am. J. Respir. Crit. Care Med. 167 (2003) No 7, Supplement, p. A373 (abstract).
[ATS 05-03 003] S. Seemann, U. Schuschnig, R. Waldner, M. Hug, M. Keller, M. Knoch: In-Vitro Characteristics of the PARI eFlow™ Electronic Inhaler. ATS 99th International Conference, Seattle, USA, May 16-21, 2003 (poster). Am. J. Respir. Crit. Care Med. 167 (2003) No 7, Supplement p. A94 (abstract).
[SMI 04-03 002] J-C Stein: From Standard Medication to an Individualized Drug Delivery Regimen SMI 4th Annual Event, London, April 30th to May 1st, 2003 (oral presentation).
[PP 01-03 001] M. Keller: The PARI eFlow™ - A sophisticated electronic nebuliser for improved pulmonary drug delivery. Pharmapack, Paris, January 29-30, 2003 (oral presentation).